nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Pain—Mitoxantrone—sarcoma	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Mitoxantrone—sarcoma	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Thiotepa—sarcoma	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Dactinomycin—sarcoma	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vincristine—sarcoma	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Etoposide—sarcoma	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Etoposide—sarcoma	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Thiotepa—sarcoma	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Infection—Etoposide—sarcoma	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Mitoxantrone—sarcoma	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Thiotepa—sarcoma	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Etoposide—sarcoma	0.000994	0.000994	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vincristine—sarcoma	0.000994	0.000994	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Vincristine—sarcoma	0.000994	0.000994	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—sarcoma	0.000992	0.000992	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Etoposide—sarcoma	0.000989	0.000989	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Etoposide—sarcoma	0.000985	0.000985	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Mitoxantrone—sarcoma	0.000973	0.000973	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Thiotepa—sarcoma	0.00097	0.00097	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Mitoxantrone—sarcoma	0.000968	0.000968	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Mitoxantrone—sarcoma	0.000968	0.000968	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000968	0.000968	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—sarcoma	0.000965	0.000965	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—sarcoma	0.000963	0.000963	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—sarcoma	0.000961	0.000961	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Etoposide—sarcoma	0.000952	0.000952	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000948	0.000948	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Thiotepa—sarcoma	0.000938	0.000938	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—sarcoma	0.000929	0.000929	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—sarcoma	0.000927	0.000927	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vincristine—sarcoma	0.000926	0.000926	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—sarcoma	0.000915	0.000915	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—sarcoma	0.000908	0.000908	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—sarcoma	0.000906	0.000906	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—sarcoma	0.000905	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Mitoxantrone—sarcoma	0.000902	0.000902	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vincristine—sarcoma	0.000902	0.000902	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Thiotepa—sarcoma	0.000901	0.000901	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—sarcoma	0.000895	0.000895	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—sarcoma	0.000895	0.000895	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—sarcoma	0.000895	0.000895	CcSEcCtD
Gadobenate Dimeglumine—Rash—Thiotepa—sarcoma	0.000894	0.000894	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—sarcoma	0.000893	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Thiotepa—sarcoma	0.000893	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Headache—Thiotepa—sarcoma	0.000888	0.000888	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—sarcoma	0.000887	0.000887	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—sarcoma	0.00088	0.00088	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—sarcoma	0.000879	0.000879	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Mitoxantrone—sarcoma	0.000878	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—sarcoma	0.000878	0.000878	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—sarcoma	0.000871	0.000871	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—sarcoma	0.000871	0.000871	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vincristine—sarcoma	0.00086	0.00086	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—sarcoma	0.000858	0.000858	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—sarcoma	0.000858	0.000858	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—sarcoma	0.000853	0.000853	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Thiotepa—sarcoma	0.000842	0.000842	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—sarcoma	0.000839	0.000839	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—sarcoma	0.000838	0.000838	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Mitoxantrone—sarcoma	0.000838	0.000838	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—sarcoma	0.000836	0.000836	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—sarcoma	0.000833	0.000833	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vincristine—sarcoma	0.000831	0.000831	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—sarcoma	0.000818	0.000818	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—sarcoma	0.000814	0.000814	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—sarcoma	0.000809	0.000809	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—sarcoma	0.000806	0.000806	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—sarcoma	0.000805	0.000805	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—sarcoma	0.000805	0.000805	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—sarcoma	0.000805	0.000805	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—sarcoma	0.000805	0.000805	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—sarcoma	0.0008	0.0008	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vincristine—sarcoma	0.000799	0.000799	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vincristine—sarcoma	0.000793	0.000793	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vincristine—sarcoma	0.000792	0.000792	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—sarcoma	0.000792	0.000792	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—sarcoma	0.000788	0.000788	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vincristine—sarcoma	0.000788	0.000788	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Mitoxantrone—sarcoma	0.000779	0.000779	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—sarcoma	0.000774	0.000774	CcSEcCtD
Gadobenate Dimeglumine—Rash—Mitoxantrone—sarcoma	0.000772	0.000772	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Mitoxantrone—sarcoma	0.000771	0.000771	CcSEcCtD
Gadobenate Dimeglumine—Headache—Mitoxantrone—sarcoma	0.000767	0.000767	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—sarcoma	0.000757	0.000757	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—sarcoma	0.000751	0.000751	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—sarcoma	0.00075	0.00075	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—sarcoma	0.000749	0.000749	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vincristine—sarcoma	0.000747	0.000747	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—sarcoma	0.000746	0.000746	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—sarcoma	0.000746	0.000746	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—sarcoma	0.000745	0.000745	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—sarcoma	0.00074	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—sarcoma	0.000732	0.000732	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—sarcoma	0.000731	0.000731	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—sarcoma	0.000731	0.000731	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—sarcoma	0.000729	0.000729	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—sarcoma	0.000729	0.000729	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Mitoxantrone—sarcoma	0.000727	0.000727	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—sarcoma	0.000726	0.000726	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—sarcoma	0.000724	0.000724	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—sarcoma	0.000721	0.000721	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—sarcoma	0.000721	0.000721	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—sarcoma	0.000718	0.000718	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—sarcoma	0.000717	0.000717	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—sarcoma	0.000704	0.000704	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—sarcoma	0.0007	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—sarcoma	0.0007	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—sarcoma	0.000697	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—sarcoma	0.000695	0.000695	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—sarcoma	0.000693	0.000693	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—sarcoma	0.00069	0.00069	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—sarcoma	0.00069	0.00069	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—sarcoma	0.000685	0.000685	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—sarcoma	0.000677	0.000677	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—sarcoma	0.000675	0.000675	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—sarcoma	0.000673	0.000673	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—sarcoma	0.000672	0.000672	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—sarcoma	0.00067	0.00067	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—sarcoma	0.000667	0.000667	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—sarcoma	0.000664	0.000664	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—sarcoma	0.000651	0.000651	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—sarcoma	0.000649	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—sarcoma	0.000648	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—sarcoma	0.000647	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—sarcoma	0.000647	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—sarcoma	0.000647	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—sarcoma	0.000642	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—sarcoma	0.000642	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—sarcoma	0.000638	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—sarcoma	0.000634	0.000634	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—sarcoma	0.000631	0.000631	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—sarcoma	0.000627	0.000627	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—sarcoma	0.000626	0.000626	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—sarcoma	0.000626	0.000626	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—sarcoma	0.000622	0.000622	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—sarcoma	0.000618	0.000618	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—sarcoma	0.000615	0.000615	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—sarcoma	0.00061	0.00061	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—sarcoma	0.000605	0.000605	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—sarcoma	0.000604	0.000604	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—sarcoma	0.000601	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—sarcoma	0.000598	0.000598	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—sarcoma	0.000588	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—sarcoma	0.000584	0.000584	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—sarcoma	0.000582	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—sarcoma	0.00058	0.00058	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—sarcoma	0.000579	0.000579	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—sarcoma	0.000576	0.000576	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—sarcoma	0.000572	0.000572	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—sarcoma	0.000571	0.000571	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—sarcoma	0.000569	0.000569	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—sarcoma	0.000567	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—sarcoma	0.000565	0.000565	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—sarcoma	0.000562	0.000562	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—sarcoma	0.00056	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—sarcoma	0.000559	0.000559	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—sarcoma	0.000557	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—sarcoma	0.000555	0.000555	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—sarcoma	0.000552	0.000552	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—sarcoma	0.000549	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000547	0.000547	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—sarcoma	0.000544	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—sarcoma	0.000539	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—sarcoma	0.000533	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—sarcoma	0.000533	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—sarcoma	0.000528	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—sarcoma	0.000525	0.000525	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00052	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—sarcoma	0.00052	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—sarcoma	0.000518	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—sarcoma	0.000516	0.000516	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—sarcoma	0.000513	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—sarcoma	0.000513	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—sarcoma	0.000511	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—sarcoma	0.000509	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—sarcoma	0.000508	0.000508	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—sarcoma	0.000503	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—sarcoma	0.000494	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000493	0.000493	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—sarcoma	0.000492	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—sarcoma	0.000488	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—sarcoma	0.000488	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000481	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—sarcoma	0.000474	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—sarcoma	0.000471	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—sarcoma	0.00047	0.00047	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—sarcoma	0.00047	0.00047	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—sarcoma	0.000467	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—sarcoma	0.000465	0.000465	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000456	0.000456	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—sarcoma	0.000455	0.000455	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—sarcoma	0.000454	0.000454	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—sarcoma	0.000452	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—sarcoma	0.000452	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—sarcoma	0.000451	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—sarcoma	0.000451	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—sarcoma	0.000435	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000432	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—sarcoma	0.000421	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—sarcoma	0.00042	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—sarcoma	0.000418	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—sarcoma	0.000418	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—sarcoma	0.00041	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—sarcoma	0.000404	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—sarcoma	0.000391	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—sarcoma	0.000389	0.000389	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—sarcoma	0.000379	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—sarcoma	0.000378	0.000378	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—sarcoma	0.000374	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—sarcoma	0.000363	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—sarcoma	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—sarcoma	0.00036	0.00036	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—sarcoma	0.00036	0.00036	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—sarcoma	0.000358	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—sarcoma	0.000349	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—sarcoma	0.000339	0.000339	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—sarcoma	0.000336	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—sarcoma	0.000333	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—sarcoma	0.000333	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—sarcoma	0.000331	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—sarcoma	0.000314	0.000314	CcSEcCtD
